Cannon Advisors
ABBV icon

Cannon Advisors’s AbbVie ABBV Stock Holding History

Cannon Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$359K Sell
1,310
-33
-2% -$8.46K 0.21% 79
2026
Q2 		$329K Hold
1,343
– – 0.2% 72
2026
Q1 		$292K Hold
1,343
– – 0.22% 67
2025
Q4 		$298K Sell
1,343
-50
-4% -$11.4K 0.21% 66
2025
Q3 		$318K Buy
1,393
+88
+7% +$17.9K 0.21% 64
2025
Q2 		$242K Buy
1,305
+19
+1% +$3.53K 0.2% 63
2025
Q1 		$269K Hold
1,286
– – 0.25% 53
2024
Q4 		$229K Sell
1,286
-20
-2% -$3.68K 0.19% 56
2024
Q3 		$254K Buy
+1,306
New +$244K 0.21% 58

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Cannon Advisors's ABBV Position: Q3 2026 in Review

Cannon Advisors reduced its AbbVie (ABBV) stake by 2.5% in Q3 2026, selling an estimated $8.46K and leaving 1,310 shares worth $359K. The position accounts for 0.21% of the portfolio, ranked #79.

Cannon Advisors first reported a position in ABBV in Q3 2024 and has held it in 9 quarters since. 1,436 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Cannon Advisors held 1,310 shares of AbbVie worth $359K as of Q3 2026.
  • Cannon Advisors sold 33 AbbVie shares in Q3 2026, an estimated $8.46K.
  • AbbVie made up 0.21% of Cannon Advisors's portfolio in Q3 2026, its #79 holding.
  • Cannon Advisors first reported a position in AbbVie in Q3 2024 and has held it in 9 quarters since.
  • 1,436 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Cannon Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.